D. E. Shaw & Co., Inc. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$12,000
-96.5%
13,274
-95.1%
0.00%
Q1 2022$339,000
+1203.8%
273,002
+1937.2%
0.00%
Q4 2021$26,000
-90.8%
13,401
-87.0%
0.00%
Q3 2021$282,000
-38.2%
102,998
-28.8%
0.00%
Q2 2021$456,000144,7540.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders